Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.
Taymaa MayMarcus BernardiniStephanie LheureuxKatja K H AbenElisa V BanderaMatthias W BeckmannJavier BenitezAndrew BerchuckLine BjørgeMichael E CarneyDaniel W CramerAnna deFazioThilo DörkDiana M EcclesMichael FriedlanderMaría Jose GarcíaEllen L GoodeAlexander HeinClaus K HøgdallAllan JensenSharon JohnattyCatherine J KennedyLambertus A KiemeneySusanne K KjærJolanta KupryjańczykKeitaro MatsuoValerie McGuireFrancesmary ModugnoLisa E PaddockTanja PejovicCatherine M PhelanMarjorie J RigganCristina Rodriguez-AntonaJoseph H RothsteinWeiva SiehHonglin SongKathryn L TerryAnne M van AltenaAdriaan VandersticheleIgnace VergoteLiv Cecilie Vestrheim ThomsenPenelope M WebbNicolas WentzensenLynne R WilkensArgyrios ZiogasHaiyan JiangAlicia Tonenull nullPublished in: Canadian journal of surgery. Journal canadien de chirurgie (2023)
This multicentre analysis indicates that complete surgical cytoreduction to no visible residual disease has the most impact on improved survival in LGSC. This finding could immediately inform and change practice.